PHARMES BELGIË
ActiveSummary
The computed 12-month bankruptcy probability of PHARMES BELGIË is 2.5% (moderate). The 2025 annual accounts show equity of €17,978 and a net result of €13,978. Its solvency ranks better than 12% of 34,946 sector peers (NACE 43, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 08-04-2024 Normal situation
- Activity
- Other construction installation NACE 43240and 3 others
- Establishment unit
- 2.358.127.804 8710 Wielsbeke, since 08-04-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Board and ownership
- DEJAGER, Mathieu Raoul FrancinaDirector
- DOMBRECHT, PieterDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.5%
- Gross margin
- €66,183
- Turnover
- ≈ €260,000
- estimated
- Profit
- €13,978
- Equity
- €17,978
- Total assets
- €291,257
- Employees on 31-12-2025
- 1
Score breakdownraises riskFounded in 20241 change of registered office in 24 monthsEquity €17,978 (6.2% of total assets)lowers riskFigures for financial year 2025 (filed on 28-04-2026)Show the evidence
Checked score
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 43, micro). It does better than 11% of them on solvency, 11% on liquidity and 48% on profitability.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Key points
- Caution: Lower solvency than 88% of companies in specialised constructionsector median 46.7% · 34,946 companies 6.2% View
Recent changes
- · Gazette deed Registered office moved from Oostrozebeke to Wielsbeke
- · Gazette deed IncorporationStarting capital €4,000 · Appointments: DOMBRECHT, Pieter (director) and DEJAGER, Mathieu Raoul Francina (director)
Comparable companies
These companies have the same main activity as PHARMES BELGIË: other construction installation (NACE 43240). They are comparable in size and age: total assets between €264,000 and €381,000, founded between 2023 and 2024.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMES BELGIË Wielsbeke | €291,257 | €66,183 |
| SKE SERVICE Langemark-Poelkapelle | €316,489 | €76,668 |
| Acrobat Construct Linter | €263,552 | €66,866 |
| CJ Zonwering Kortenberg | €338,108 | €74,573 |
| OH MY KEY Chaumont-Gistoux | €381,344 | €67,744 |
| Foliefixx Maaseik | €296,850 | €65,824 |
| THERMOMATTE Wezembeek-Oppem | €275,256 | €98,901 |
Key facts about PHARMES BELGIË
- What is the company number of PHARMES BELGIË?
- The company number of PHARMES BELGIË is 1008.128.324. The VAT number is the same number with BE in front: BE 1008.128.324.
- Where is PHARMES BELGIË based?
- The registered office is at Tumulusstraat 4, 8710 Wielsbeke.Company details
- What does PHARMES BELGIË do?
- According to the KBO register, the main activity is other construction installation (NACE 43240).
- What is the legal form of PHARMES BELGIË?
- The legal form of PHARMES BELGIË is Private limited company (BV).
- When was PHARMES BELGIË founded?
- PHARMES BELGIË was founded on 08-04-2024.
- Is PHARMES BELGIË still active?
- Yes, PHARMES BELGIË is an active enterprise in the KBO register.
- How many employees does PHARMES BELGIË have?
- PHARMES BELGIË had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PHARMES BELGIË?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €66,183 and 108 comparable companies (NACE 432). It probably lies between €190,000 and €380,000.
- Is PHARMES BELGIË profitable?
- In financial year 2025, PHARMES BELGIË made a profit of €13,978.
- Where can I find the annual accounts of PHARMES BELGIË?
- PHARMES BELGIË filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.